Javascript must be enabled to continue!
Pharmacotherapy of Hypoactive Sexual Desire
View through CrossRef
The article reports that hypoactive sexual desire occurs quite often in both sexes, but in women, such a complaint came to the first position. The article is devoted to the presentation and discussion of various medications and dietary supplements used to enhance sexual desire in women and men. Adaptogens is reported to enhance libido. Flibanserin was the first drug approved in the United States by the Food and Drug Administration (FDA) for the treatment of acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Testosterone is used in men and women with a weakened libido, and Tibolone enhances sexual desire in women.
Also reported on the use of bremelanotide, the second drug approved by the FDA for the treatment of acquired generalized HSDD in premenopausal women, which is also used to increase sexual desire in men. It is informed that it also increases libido in men. In addition, bupropion and its combination with trazadone have been reported to enhance libido in women. Buspirone is reportedly used to treat sexual side effects, including diminished libido, caused by antidepressants from the selective serotonin reuptake inhibitor group.
It has been noted that the enhancing sex drive in men and women may cause Tribulus Terrestris L. use and drugs created on its basis (Tribestan and its analogues). To enhance the sexual desire, two combined drugs are tested: testosterone + sildenafil and testosterone + buspirone. Also named a number of biologically active supplements used to strengthen the weakened libido and eliminate other sexual dysfunctions.
Title: Pharmacotherapy of Hypoactive Sexual Desire
Description:
The article reports that hypoactive sexual desire occurs quite often in both sexes, but in women, such a complaint came to the first position.
The article is devoted to the presentation and discussion of various medications and dietary supplements used to enhance sexual desire in women and men.
Adaptogens is reported to enhance libido.
Flibanserin was the first drug approved in the United States by the Food and Drug Administration (FDA) for the treatment of acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Testosterone is used in men and women with a weakened libido, and Tibolone enhances sexual desire in women.
Also reported on the use of bremelanotide, the second drug approved by the FDA for the treatment of acquired generalized HSDD in premenopausal women, which is also used to increase sexual desire in men.
It is informed that it also increases libido in men.
In addition, bupropion and its combination with trazadone have been reported to enhance libido in women.
Buspirone is reportedly used to treat sexual side effects, including diminished libido, caused by antidepressants from the selective serotonin reuptake inhibitor group.
It has been noted that the enhancing sex drive in men and women may cause Tribulus Terrestris L.
use and drugs created on its basis (Tribestan and its analogues).
To enhance the sexual desire, two combined drugs are tested: testosterone + sildenafil and testosterone + buspirone.
Also named a number of biologically active supplements used to strengthen the weakened libido and eliminate other sexual dysfunctions.
Related Results
The Object of Sexual Desire: Examining the “What” in “What Do You Desire?”
The Object of Sexual Desire: Examining the “What” in “What Do You Desire?”
Abstract
Introduction
Over the past two decades, sexual desire and desire discrepancy have become more frequently studied as hav...
ORIGINAL RESEARCH—PSYCHOLOGY: Sexual Desire in Women: An Integrative Approach Regarding Psychological, Medical, and Relationship Dimensions
ORIGINAL RESEARCH—PSYCHOLOGY: Sexual Desire in Women: An Integrative Approach Regarding Psychological, Medical, and Relationship Dimensions
ABSTRACT
Introduction
Sexual desire depends on the balance between biologic, psychological, and cultural values. Therefore, conc...
277 Evaluation of the Sexual Desire Disorders in the Post-Partum Period
277 Evaluation of the Sexual Desire Disorders in the Post-Partum Period
ABSTRACT
Introduction
A woman's sexuality changes throughout her life and varies according to endogenous and exogenous factors. ...
The role of sexual self-esteem, sexual desire, and sexual assertiveness in the female sexual function
The role of sexual self-esteem, sexual desire, and sexual assertiveness in the female sexual function
Abstract
Background
Sexual function plays a very important role in the sexual health of people, and the determination of their related factors refle...
Gepirone-ER Treatment of Low Sexual Desire Associated with Depression in Women as Measured by the DeRogatis Inventory of Sexual Function (DISF) Fantasy/Cognition (Desire) Domain—A Post Hoc Analysis
Gepirone-ER Treatment of Low Sexual Desire Associated with Depression in Women as Measured by the DeRogatis Inventory of Sexual Function (DISF) Fantasy/Cognition (Desire) Domain—A Post Hoc Analysis
ABSTRACT
Introduction
Gepirone-extended release (ER) is effective in treating hypoactive sexual desire disorder (HSDD), as measu...
(63) SEXUAL SELF-CONCEPT OF MIDDLE-AGED MEN AND ASSOCIATIONS WITH THEIR SEX LIVES: RESULTS FROM THE BAVARIAN MEN’S HEALTH STUDY
(63) SEXUAL SELF-CONCEPT OF MIDDLE-AGED MEN AND ASSOCIATIONS WITH THEIR SEX LIVES: RESULTS FROM THE BAVARIAN MEN’S HEALTH STUDY
Abstract
Objectives
The sexual self-concept is a major component of sexual health. The aim of this study was to investigate asso...
PMON214 Kisspeptin Restores Sexual and Attraction Brain Processing in Women with Hypoactive Sexual Desire Disorder
PMON214 Kisspeptin Restores Sexual and Attraction Brain Processing in Women with Hypoactive Sexual Desire Disorder
Abstract
Introduction
Sexual desire is a key component of the sexual response model. Absence or deficiency of sexual desire can ...
Parental Attitudes Toward ADHD Pharmacotherapy: Associations with Parental Experience of the Child’s Treatment—A Cross-Sectional Study from Poland
Parental Attitudes Toward ADHD Pharmacotherapy: Associations with Parental Experience of the Child’s Treatment—A Cross-Sectional Study from Poland
Background: The efficacy of pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) has been confirmed in numerous controlled studies. However, in clinical practice, ph...

